Lupin Strengthens Diabetes Portfolio with Acquisition of Three Anti-Diabetes Trademarks from Boehringer Ingelheim
Lupin Limited, a global pharmaceutical leader, has announced the strategic acquisition of three prominent anti-diabetes trademarks—Gibtulio, Gibtulio Met, and Ajaduo—from […]
